Hey Dan,
The Combined NAL + Authier Operation will be a near term Spodumene Concentrate operation starting in H1 2023, so technically speaking they are a near producer of concentrate material which will be the main output until the end of 2025 if all goes to plan
The downstream value addition processing plans will be studied over the coming period.
- Pre-Feasibility Study being completed by Hatch due in 6 months time (March 2023), will determine the best product stream to deliver value for the JV; followed by
- Definitive Feasibility Study will commence likely towards the end of Q2 2023, allowance for ~6-9 months to complete should see it released towards Christmas 2023 / Early 2024 (The JV is required to deliver a Final Feasibility prior to August 2024)
The JV will then be in a position to make a decision in H1 2024 on how to proceed, secure the required CAPEX, complete Detailed Engineering, EPC etc
A roughly 18 month build would see 1st refined product leaving NAL at the end of 2025. Meaning that the project will be a producer of Spodumene Concentrate for ~3 years (If all goes to plan, the path is agreed to and there are no unforeseen delays)
Hey Dan,The Combined NAL + Authier Operation will be a near term...
Add SYA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
-0.001(2.78%) |
Mkt cap ! $360.2M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.7¢ | 3.5¢ | $1.685M | 47.16M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 6087983 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 4590718 | 15 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| SYA (ASX) Chart |